Response-letter to the editor: colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns

Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e72-e73. doi: 10.1093/ehjcvp/pvab024.

Authors

Mattia Galli^{1

2}, Giuseppe Princi¹, Filippo Crea¹, Domenico D'Amario¹

Affiliations

¹ Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, Largo Francesco Vito 1, Roma 00168, Italy.
² Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA.

PMID: 33725116
DOI: 10.1093/ehjcvp/pvab024

No abstract available

Publication types

Letter
Comment

MeSH terms

Colchicine* / adverse effects
Coronary Artery Disease* / drug therapy
Humans
Secondary Prevention

Substances

Colchicine